(Q48404030)

English

Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

0 references

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

author name string

Lione LA

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

Nutt DJ

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

European Journal of Pharmacology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

353

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

123-135

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Quantitative autoradiographic localization of alpha 2-antagonist binding sites in rat brain using [3H]idazoxan.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Isolation of a human cerebral imidazoline-specific binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

[3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Identification of ligands selective for central I2-imidazoline binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

The effects of idazoxan and other α2-adrenoceptor antagonists on food and water intake in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Binding of [3H]p-aminoclonidine to two sites, alpha 2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Alpha 2-adrenoceptor and catecholamine-insensitive binding sites for [3H]rilmenidine in membranes from rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Agmatine: an endogenous clonidine-displacing substance in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

[3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

[3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Are there multiple imidazoline binding sites?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Functional studies of specific imidazoline-2 receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Pharmacological and molecular discrimination of brain I2-imidazoline receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

The elusive family of imidazoline binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Imidazoline binding sites in Huntington's and Parkinson's disease putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan-receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Evidence that drug binding to non-adrenergic [3H]-idazoxan binding sites (I-receptors) occurs to interacting or interconvertible affinity forms of the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900389-6

7 January 2021

Identifiers

10.1016/S0014-2999(98)00389-6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9721049

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48404030&oldid=1373067624"